Crossbow Therapeutics
Business Services · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1030 Massachusetts Ave Ste 210, Cambridg...Phone Number
(860) 501-1600Website
www.crossbowtx.comRevenue
$10.1 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
2
1
1
About Crossbow Therapeutics
Crossbow Therapeutics is a biotechnology company focused on developing advanced antibody-based treatments for cancer, and from a third-party perspective it is seen as an innovation-driven organization working in the immunotherapy space. It is recognized for designing engineered molecules that replicate natural immune responses to better target complex cancer cells, while aiming to expand the reach of precision therapies and contribute to improved treatment approaches in oncology.Explore more
Crossbow Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Crossbow Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Crossbow Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Crossbow Therapeutics has new funding data
Check out if Crossbow Therapeutics is spiking on competitors!
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Crossbow Therapeutics
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Crossbow Therapeutics recently announced quarterly report
Crossbow Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Crossbow Therapeutics launches new products
Click to see if Crossbow Therapeutics had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined Crossbow Therapeutics as Masked Content
Find 3 more new buyers
Compare Similar Companies to Crossbow Therapeutics
Compare insights from companies similar to Crossbow Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Crossbow Therapeutics
$10.1M
11-50
Private
$187.3M
2021
MW
Mark WeinsteinChief Information Officer & Advisor
<$5M
11-50
Private
$56.1M
2021
Company Profile Activity
Activity Insights
Crossbow Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Crossbow Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Crossbow Therapeutics.
Crossbow Therapeutics financials insights
Gather financial insights about Crossbow Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2023
Series A
$80M
2025
Private Equity
$30.3M
2026
Series B
$77M
Crossbow Therapeutics Tech Stack
Most Recent Scoops
Funding
Funding
Project
Laboratory Operations, Medical Research, Clinical Operations
Executive Move
Executive Moves, Board of Directors
Funding
Funding
Person-Based
Crossbow Therapeutics News & Media
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Crossbow Therapeutics
Sign Up For FreeTo access detailed company insights
Crossbow Therapeutics is a biotechnology company focused on developing advanced antibody-based treatments for cancer, and from a third-party perspective it is seen as an innovation-driven organization working in the immunotherapy space. It is recognized for designing engineered molecules that replicate natural immune responses to better target comp... Read More
